home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Metastasis Blocked

 
  April, 12 2006 9:09
your information resource in human molecular genetics
 
     
An international research team has identified what may be a pivotal molecule in the ability of tumours to metastasize - or spread - into bone. Metastases are responsible for more cancer deaths than primary tumours, and bone is a particularly fertile site into which other cancers often spread. Researchers have long hypothesized that bone tissue might manufacture certain molecules that entice cancer cells to lodge there.

In the 30 Mar 06 issue of Nature (Vol. 440, No. 7084, pp. 692-696), Josef Penninger and his colleagues present evidence that a cytokine protein called RANKL, which is produced at high levels in bone marrow, acts through the RANK receptor on breast, prostate and skin cancer cells and triggers their migration.

In a mouse model of melanoma, the team shows that blocking the action of RANKL prevents the cancer from metastasizing to the bones but not other organs, and protects the animals from paralysis and death. Drugs that inhibit RANKL or its receptor might also block human metastases in bone, they suggest.

CONTACT

Josef Penninger (Austrian Academy of Sciences, Vienna, Austria)
E-mail: josef.penninger@imba.oeaw.ac.at

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.